NOS3 and metabolic dysfunction-associated steatotic liver disease: In this review, we posit that one potential mediator of hepatic mitochondrial dysfunction and NAFLD progression is the loss of endothelial nitric oxide synthase (eNOS), and its product nitric oxide (NO), due to this enzyme’s well-established role in metabolic health and mitochondrial dynamics (discussed later).